Akari Therapeutics (AKTX) Market Cap to FCF (2014 - 2026)

Akari Therapeutics (AKTX) Market Cap to FCF (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Market Cap to FCF
1 Oculis Holding AG 66,681.27 Bn 66,680.98 Bn - -858,267.11
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn - -49,404.47
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -87,984.29
4 BeOne Medicines 472.75 Bn 467.96 Bn 1.35 Bn 379.93
5 Vertex Pharmaceuticals 122.14 Bn 114.89 Bn 2.59 Bn 32.92
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn 17.04
7 Belite Bio 62.34 Bn 62.34 Bn - -6,003.27
8 Argenx Se 55.94 Bn 50.76 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn 58.32
10 Revolution Medicines 37.28 Bn 37.28 Bn - -34.80

Historic Data

Download Data
DateValue
Jul 23, 2026 -7.94
Jul 22, 2026 -8.37
Jul 21, 2026 -7.94
Jul 20, 2026 -9.10
Jul 17, 2026 -9.39
Jul 16, 2026 -9.90
Jul 15, 2026 -10.30
Jul 14, 2026 -11.45
Jul 13, 2026 -11.43
Jul 10, 2026 -11.84
Jul 9, 2026 -11.23
Jul 8, 2026 -12.13
Jul 7, 2026 -13.21
Jul 6, 2026 -9.30
Jul 2, 2026 -8.88
Jul 1, 2026 -8.75
Jun 30, 2026 -8.74
Jun 29, 2026 -8.27
Jun 26, 2026 -9.16
Jun 25, 2026 -8.12